Header cover image
  • Investing Ideas
  • Malaysian Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Malaysian Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Results

1

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

Duopharma Biotech Berhad

Market Cap: RM 1.2b

Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.

DPHARMA

RM 1.24

7D

0.8%

1Y

-8.8%